KEYRUS (ALKEY.PA) Fundamental Analysis & Valuation

EPA:ALKEY • FR0004029411

Current stock price

7.36 EUR
-0.08 (-1.08%)
Last:

This ALKEY.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ALKEY.PA Profitability Analysis

1.1 Basic Checks

  • ALKEY had positive earnings in the past year.
  • ALKEY had a positive operating cash flow in the past year.
  • ALKEY had positive earnings in 4 of the past 5 years.
  • ALKEY had a positive operating cash flow in each of the past 5 years.
ALKEY.PA Yearly Net Income VS EBIT VS OCF VS FCFALKEY.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

1.2 Ratios

  • ALKEY's Return On Assets of 4.61% is fine compared to the rest of the industry. ALKEY outperforms 61.04% of its industry peers.
  • The Return On Equity of ALKEY (24.11%) is better than 84.42% of its industry peers.
  • With a Return On Invested Capital value of 5.94%, ALKEY perfoms like the industry average, outperforming 44.16% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALKEY is below the industry average of 11.58%.
Industry RankSector Rank
ROA 4.61%
ROE 24.11%
ROIC 5.94%
ROA(3y)0.78%
ROA(5y)0.69%
ROE(3y)6.29%
ROE(5y)5.58%
ROIC(3y)7.32%
ROIC(5y)6.28%
ALKEY.PA Yearly ROA, ROE, ROICALKEY.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

  • ALKEY has a Profit Margin (4.28%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of ALKEY has declined.
  • ALKEY's Operating Margin of 3.77% is on the low side compared to the rest of the industry. ALKEY is outperformed by 61.04% of its industry peers.
  • In the last couple of years the Operating Margin of ALKEY has grown nicely.
  • ALKEY has a Gross Margin (62.21%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of ALKEY has remained more or less at the same level.
Industry RankSector Rank
OM 3.77%
PM (TTM) 4.28%
GM 62.21%
OM growth 3Y6.09%
OM growth 5Y16.8%
PM growth 3Y-45.66%
PM growth 5YN/A
GM growth 3Y-1.57%
GM growth 5Y-0.7%
ALKEY.PA Yearly Profit, Operating, Gross MarginsALKEY.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. ALKEY.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALKEY is creating some value.
  • ALKEY has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALKEY has been increased compared to 5 years ago.
  • ALKEY has a better debt/assets ratio than last year.
ALKEY.PA Yearly Shares OutstandingALKEY.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ALKEY.PA Yearly Total Debt VS Total AssetsALKEY.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • ALKEY has an Altman-Z score of 1.69. This is a bad value and indicates that ALKEY is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of ALKEY (1.69) is worse than 63.64% of its industry peers.
  • The Debt to FCF ratio of ALKEY is 10.83, which is on the high side as it means it would take ALKEY, 10.83 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 10.83, ALKEY is doing worse than 66.23% of the companies in the same industry.
  • ALKEY has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.16, ALKEY is doing worse than 64.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 10.83
Altman-Z 1.69
ROIC/WACC0.88
WACC6.78%
ALKEY.PA Yearly LT Debt VS Equity VS FCFALKEY.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • ALKEY has a Current Ratio of 1.02. This is a normal value and indicates that ALKEY is financially healthy and should not expect problems in meeting its short term obligations.
  • ALKEY has a worse Current ratio (1.02) than 63.64% of its industry peers.
  • A Quick Ratio of 1.02 indicates that ALKEY should not have too much problems paying its short term obligations.
  • ALKEY has a Quick ratio of 1.02. This is comparable to the rest of the industry: ALKEY outperforms 40.26% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
ALKEY.PA Yearly Current Assets VS Current LiabilitesALKEY.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2

3. ALKEY.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 972.01% over the past year.
  • Measured over the past years, ALKEY shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -41.84% on average per year.
  • ALKEY shows a decrease in Revenue. In the last year, the revenue decreased by -4.15%.
  • ALKEY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.34% yearly.
EPS 1Y (TTM)972.01%
EPS 3Y-41.84%
EPS 5YN/A
EPS Q2Q%599.66%
Revenue 1Y (TTM)-4.15%
Revenue growth 3Y7.03%
Revenue growth 5Y4.34%
Sales Q2Q%-4.43%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALKEY.PA Yearly Revenue VS EstimatesALKEY.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

4. ALKEY.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.91 indicates a rather cheap valuation of ALKEY.
  • ALKEY's Price/Earnings ratio is rather cheap when compared to the industry. ALKEY is cheaper than 97.40% of the companies in the same industry.
  • ALKEY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.95.
Industry RankSector Rank
PE 7.91
Fwd PE N/A
ALKEY.PA Price Earnings VS Forward Price EarningsALKEY.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALKEY indicates a slightly more expensive valuation: ALKEY is more expensive than 61.04% of the companies listed in the same industry.
  • ALKEY's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 15.05
EV/EBITDA 10.34
ALKEY.PA Per share dataALKEY.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. ALKEY.PA Dividend Analysis

5.1 Amount

  • No dividends for ALKEY!.
Industry RankSector Rank
Dividend Yield 0%

ALKEY.PA Fundamentals: All Metrics, Ratios and Statistics

KEYRUS

EPA:ALKEY (4/17/2026, 7:00:00 PM)

7.36

-0.08 (-1.08%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)09-29
Earnings (Next)N/A
Inst Owners1.76%
Inst Owner ChangeN/A
Ins Owners71.48%
Ins Owner ChangeN/A
Market Cap127.18M
Revenue(TTM)346.70M
Net Income(TTM)14.84M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.91
Fwd PE N/A
P/S 0.37
P/FCF 15.05
P/OCF 11.36
P/B 2.07
P/tB N/A
EV/EBITDA 10.34
EPS(TTM)0.93
EY12.64%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.49
FCFY6.65%
OCF(TTM)0.65
OCFY8.8%
SpS20.06
BVpS3.56
TBVpS-2.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.63165 (17.28%)
Profitability
Industry RankSector Rank
ROA 4.61%
ROE 24.11%
ROCE 8.09%
ROIC 5.94%
ROICexc 6.05%
ROICexgc 15.5%
OM 3.77%
PM (TTM) 4.28%
GM 62.21%
FCFM 2.44%
ROA(3y)0.78%
ROA(5y)0.69%
ROE(3y)6.29%
ROE(5y)5.58%
ROIC(3y)7.32%
ROIC(5y)6.28%
ROICexc(3y)10.93%
ROICexc(5y)9.65%
ROICexgc(3y)89.94%
ROICexgc(5y)79.55%
ROCE(3y)9.96%
ROCE(5y)8.54%
ROICexgc growth 3Y7.19%
ROICexgc growth 5Y45.09%
ROICexc growth 3Y5.95%
ROICexc growth 5Y18.68%
OM growth 3Y6.09%
OM growth 5Y16.8%
PM growth 3Y-45.66%
PM growth 5YN/A
GM growth 3Y-1.57%
GM growth 5Y-0.7%
F-Score5
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 10.83
Debt/EBITDA 3.43
Cap/Depr 35.24%
Cap/Sales 0.79%
Interest Coverage 2.34
Cash Conversion 53.66%
Profit Quality 56.98%
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 1.69
F-Score5
WACC6.78%
ROIC/WACC0.88
Cap/Depr(3y)26.72%
Cap/Depr(5y)28.98%
Cap/Sales(3y)0.72%
Cap/Sales(5y)0.94%
Profit Quality(3y)940.02%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)972.01%
EPS 3Y-41.84%
EPS 5YN/A
EPS Q2Q%599.66%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.15%
Revenue growth 3Y7.03%
Revenue growth 5Y4.34%
Sales Q2Q%-4.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.54%
EBIT growth 3Y13.55%
EBIT growth 5Y21.87%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.87%
FCF growth 3Y16.43%
FCF growth 5Y22.68%
OCF growth 1Y-34.17%
OCF growth 3Y13.37%
OCF growth 5Y11.49%

KEYRUS / ALKEY.PA Fundamental Analysis FAQ

What is the fundamental rating for ALKEY stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALKEY.PA.


What is the valuation status for ALKEY stock?

ChartMill assigns a valuation rating of 3 / 10 to KEYRUS (ALKEY.PA). This can be considered as Overvalued.


How profitable is KEYRUS (ALKEY.PA) stock?

KEYRUS (ALKEY.PA) has a profitability rating of 5 / 10.